Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Assertio Holdings EBITDA Margin 2010-2025 | ASRT

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Assertio Holdings (ASRT) over the last 10 years. The current EBITDA margin for Assertio Holdings as of March 31, 2025 is .
  
Assertio Holdings EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2025-03-31 $0.12B $0.00B -2.54%
2024-12-31 $0.12B $0.00B 1.61%
2024-09-30 $0.13B $-0.02B -15.20%
2024-06-30 $0.13B $-0.24B -182.58%
2024-03-31 $0.14B $-0.23B -158.45%
2023-12-31 $0.15B $-0.22B -141.45%
2023-09-30 $0.17B $-0.17B -100.00%
2023-06-30 $0.17B $0.06B 38.32%
2023-03-31 $0.16B $0.06B 39.75%
2022-12-31 $0.16B $0.07B 46.79%
2022-09-30 $0.14B $0.07B 49.64%
2022-06-30 $0.13B $0.07B 51.54%
2022-03-31 $0.12B $0.04B 36.67%
2021-12-31 $0.11B $0.04B 34.55%
2021-09-30 $0.11B $0.00B -2.80%
2021-06-30 $0.12B $-0.02B -13.68%
2021-03-31 $0.11B $-0.03B -28.32%
2020-12-31 $0.11B $-0.05B -45.79%
2020-09-30 $0.14B $-0.18B -134.56%
2020-06-30 $0.16B $-0.16B -103.85%
2020-03-31 $0.19B $-0.11B -55.73%
2019-12-31 $0.23B $-0.07B -30.13%
2019-09-30 $0.21B $0.11B 51.17%
2019-06-30 $0.24B $0.13B 55.32%
2019-03-31 $0.24B $0.12B 51.04%
2018-12-31 $0.31B $0.17B 55.31%
2018-09-30 $0.36B $0.15B 42.27%
2018-06-30 $0.38B $0.14B 37.63%
2018-03-31 $0.42B $0.14B 34.05%
2017-12-31 $0.38B $0.08B 21.64%
2017-09-30 $0.41B $0.13B 32.27%
2017-06-30 $0.43B $0.13B 31.29%
2017-03-31 $0.44B $0.15B 33.48%
2016-12-31 $0.46B $0.15B 33.26%
2016-09-30 $0.44B $0.11B 24.32%
2016-06-30 $0.44B $0.11B 25.11%
2016-03-31 $0.42B $0.08B 19.71%
2015-12-31 $0.34B $0.05B 14.87%
2015-09-30 $0.43B $0.21B 49.18%
2015-06-30 $0.37B $0.20B 52.55%
2015-03-31 $0.35B $0.21B 61.27%
2014-12-31 $0.39B $0.25B 64.96%
2014-09-30 $0.24B $0.10B 42.62%
2014-06-30 $0.22B $0.09B 39.46%
2014-03-31 $0.19B $0.06B 32.43%
2013-12-31 $0.13B $0.02B 12.69%
2013-09-30 $0.12B $0.00B 2.50%
2013-06-30 $0.12B $-0.01B -5.17%
2013-03-31 $0.10B $-0.02B -23.00%
2012-12-31 $0.09B $-0.03B -30.77%
2012-09-30 $0.08B $-0.04B -50.00%
2012-06-30 $0.06B $-0.05B -76.67%
2012-03-31 $0.07B $-0.04B -55.22%
2011-12-31 $0.13B $0.07B 53.38%
2011-09-30 $0.14B $0.09B 59.86%
2011-06-30 $0.15B $0.10B 66.21%
2011-03-31 $0.15B $0.11B 71.62%
2010-12-31 $0.08B $0.00B 3.75%
2010-09-30 $0.07B $0.00B -2.78%
2010-06-30 $0.08B $0.00B -2.67%
2010-03-31 $0.06B $-0.02B -23.81%
2009-12-31 $0.06B $-0.02B -36.21%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.061B $0.125B
Assertio Holdings Inc. is a specialty pharmaceutical company. Its portfolio consists of branded prescription neurology, inflammation and pain medications. The company's business development includes acquisitions, licensing and mergers. Assertio Holdings Inc., formerly known as Assertio Therapeutics Inc., is based in LAKE FOREST, Ill.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $85.797B 32.19
Zoetis (ZTS) United States $69.430B 25.91
Takeda Pharmaceutical (TAK) Japan $49.193B 9.78
Daiichi Sankyo, - (DSNKY) Japan $43.987B 22.54
BeOne Medicines - (ONC) Cayman Islands $26.531B 0.00
Sandoz Group AG (SDZNY) Switzerland $24.053B 0.00
Merck (MKKGY) Germany $16.763B 12.28
Summit Therapeutics (SMMT) United States $15.804B 0.00
Shionogi (SGIOY) Japan $15.161B 15.19
United Therapeutics (UTHR) United States $12.961B 11.47
Neurocrine Biosciences (NBIX) United States $12.439B 42.61
Orion OYJ (ORINY) Finland $10.495B 28.38
IPSEN (IPSEY) France $10.108B 0.00
Corcept Therapeutics (CORT) United States $7.784B 63.28
Stevanato Group S.p.A (STVN) Italy $7.398B 45.24
Madrigal Pharmaceuticals (MDGL) United States $6.720B 0.00
Ionis Pharmaceuticals (IONS) United States $6.288B 0.00
Grifols, S.A (GRFS) Spain $6.216B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.382B 13.33
Soleno Therapeutics (SLNO) United States $4.222B 0.00
Hypermarcas (HYPMY) Brazil $3.059B 20.12
Crinetics Pharmaceuticals (CRNX) United States $2.693B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.647B 9.27
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.536B 13.71
NewAmsterdam Pharma (NAMS) Netherlands $2.033B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.875B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.755B 0.00
ARS Pharmaceuticals (SPRY) United States $1.714B 0.00
Endo (NDOI) United States $1.602B 0.00
Evotec AG (EVO) Germany $1.491B 0.00
Ocular Therapeutix (OCUL) United States $1.478B 0.00
Guardian Pharmacy Services (GRDN) United States $1.349B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.144B 22.89
Harrow (HROW) United States $1.120B 0.00
Dyne Therapeutics (DYN) United States $1.082B 0.00
Verve Therapeutics (VERV) United States $1.001B 0.00
Enliven Therapeutics (ELVN) United States $0.984B 0.00
Akebia Therapeutics (AKBA) United States $0.956B 0.00
Collegium Pharmaceutical (COLL) United States $0.950B 5.12
Ardelyx (ARDX) United States $0.938B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.856B 0.00
Elite Pharmaceuticals (ELTP) United States $0.782B 0.00
Cronos Group (CRON) Canada $0.737B 0.00
Xeris Biopharma Holdings (XERS) United States $0.730B 0.00
Relay Therapeutics (RLAY) United States $0.593B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.571B 0.00
USANA Health Sciences (USNA) United States $0.569B 12.36
KalVista Pharmaceuticals (KALV) United States $0.562B 0.00
Xencor (XNCR) United States $0.559B 0.00
Theravance Biopharma (TBPH) United States $0.552B 0.00
Bioventus (BVS) United States $0.544B 13.79
Zevra Therapeutics (ZVRA) United States $0.482B 0.00
AleAnna (ANNA) United States $0.480B 0.00
Siga Technologies (SIGA) United States $0.466B 9.73
Organogenesis (ORGO) United States $0.464B 0.00
Oruka Therapeutics (ORKA) United States $0.420B 0.00
Tourmaline Bio (TRML) United States $0.411B 0.00
Savara (SVRA) United States $0.394B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.335B 9.05
Aquestive Therapeutics (AQST) United States $0.329B 0.00
Nektar Therapeutics (NKTR) United States $0.321B 0.00
Heron Therapeutics (HRTX) United States $0.316B 0.00
Altimmune (ALT) United States $0.314B 0.00
Liminatus Pharma (LIMN) United States $0.290B 0.00
Nature's Sunshine Products (NATR) United States $0.273B 25.07
Tonix Pharmaceuticals Holding (TNXP) United States $0.265B 0.00
Aldeyra Therapeutics (ALDX) United States $0.229B 0.00
Nanobiotix S.A (NBTX) France $0.223B 0.00
OmniAb (OABI) United States $0.213B 0.00
MediWound (MDWD) Israel $0.209B 0.00
Esperion Therapeutics (ESPR) United States $0.195B 0.00
Larimar Therapeutics (LRMR) United States $0.185B 0.00
Profound Medical (PROF) Canada $0.177B 0.00
ProKidney (PROK) United States $0.173B 0.00
4D Molecular Therapeutics (FDMT) United States $0.172B 0.00
Journey Medical (DERM) United States $0.167B 0.00
Innate Pharma SA (IPHYF) France $0.163B 0.00
Aclaris Therapeutics (ACRS) United States $0.154B 0.00
Inhibikase Therapeutics (IKT) United States $0.145B 0.00
Avita Medical (RCEL) United States $0.140B 0.00
Galectin Therapeutics (GALT) United States $0.134B 0.00
Lexeo Therapeutics (LXEO) United States $0.133B 0.00
Lyell Immunopharma (LYEL) United States $0.131B 0.00
Korro Bio (KRRO) United States $0.117B 0.00
Protara Therapeutics (TARA) United States $0.117B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.116B 0.00
Cardiol Therapeutics (CRDL) Canada $0.112B 0.00
VAXART, INC (VXRT) United States $0.103B 0.00
Champions Oncology (CSBR) United States $0.102B 16.75
Nutriband (NTRB) United States $0.088B 0.00
Cassava Sciences (SAVA) United States $0.087B 0.00
Arch Biopartners (ACHFF) Canada $0.086B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.084B 0.00
Dominari Holdings (DOMH) United States $0.080B 0.00
Fractyl Health (GUTS) United States $0.079B 0.00
Achieve Life Sciences (ACHV) Canada $0.078B 0.00
Surrozen (SRZN) United States $0.077B 0.00
Vivani Medical (VANI) United States $0.076B 0.00
ESSA Pharma (EPIX) Canada $0.075B 0.00
Wellgistics Health (WGRX) United States $0.070B 0.00
Pyxis Oncology (PYXS) United States $0.068B 0.00
Inotiv (NOTV) United States $0.063B 0.00
Rafael Holdings (RFL) United States $0.061B 0.00
Unicycive Therapeutics (UNCY) United States $0.060B 0.00
Context Therapeutics (CNTX) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
NRx Pharmaceuticals (NRXP) United States $0.056B 0.00
Metagenomi (MGX) United States $0.055B 0.00
PMV Pharmaceuticals (PMVP) United States $0.055B 0.00
Avalo Therapeutics (AVTX) United States $0.054B 0.00
Gain Therapeutics (GANX) United States $0.054B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.050B 37.22
Verrica Pharmaceuticals (VRCA) United States $0.049B 0.00
Century Therapeutics (IPSC) United States $0.048B 0.00
Prelude Therapeutics (PRLD) United States $0.046B 0.00
Mural Oncology (MURA) Ireland $0.043B 0.00
Iterum Therapeutics (ITRM) Ireland $0.040B 0.00
ElectroCore (ECOR) United States $0.039B 0.00
Acrivon Therapeutics (ACRV) United States $0.037B 0.00
Karyopharm Therapeutics (KPTI) United States $0.037B 0.00
Telomir Pharmaceuticals (TELO) United States $0.037B 0.00
Klotho Neurosciences (KLTO) United States $0.037B 0.00
PolyPid (PYPD) Israel $0.036B 0.00
Jupiter Neurosciences (JUNS) United States $0.034B 0.00
China SXT Pharmaceuticals (SXTC) China $0.027B 0.00
Enlivex Therapeutics (ENLV) Israel $0.026B 0.00
SCYNEXIS (SCYX) United States $0.026B 0.00
VYNE Therapeutics (VYNE) United States $0.025B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
FibroGen (FGEN) United States $0.021B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
Relmada Therapeutics (RLMD) United States $0.020B 0.00
DURECT (DRRX) United States $0.020B 0.00
BioLineRx (BLRX) Israel $0.019B 0.00
Vivos Therapeutics (VVOS) United States $0.019B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.018B 0.00
Mannatech (MTEX) United States $0.018B 0.00
Plus Therapeutics (PSTV) United States $0.018B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.017B 0.00
BioVie (BIVI) United States $0.017B 0.00
Citius Pharmaceuticals (CTXR) United States $0.017B 0.00
Lipocine (LPCN) United States $0.017B 0.00
Carisma Therapeutics (CARM) United States $0.016B 0.00
ProPhase Labs (PRPH) United States $0.016B 0.00
CASI Pharmaceuticals (CASI) China $0.015B 0.00
Scienture Holdings (SCNX) United States $0.014B 0.00
Ernexa Therapeutics (ERNA) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Cosmos Health (COSM) United States $0.012B 0.00
Minerva Neurosciences (NERV) United States $0.012B 2.10
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Ainos (AIMD) United States $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.011B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
Talphera (TLPH) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Alaunos Therapeutics (TCRT) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
SHINECO (SISI) China $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 8.62
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00